AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Vigil Neuroscience Statistics
Share Statistics
Vigil Neuroscience has 40.88M shares outstanding. The number of shares has increased by 10.83% in one year.
Shares Outstanding | 40.88M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 3.11% |
Owned by Institutions (%) | n/a |
Shares Floating | 19.36M |
Failed to Deliver (FTD) Shares | 15.68K |
FTD / Avg. Volume | 7.39% |
Short Selling Information
The latest short interest is 513.30K, so 1.26% of the outstanding shares have been sold short.
Short Interest | 513.30K |
Short % of Shares Out | 1.26% |
Short % of Float | 2.65% |
Short Ratio (days to cover) | 5.31 |
Valuation Ratios
The PE ratio is -1.58 and the forward PE ratio is -2.01.
PE Ratio | -1.58 |
Forward PE | -2.01 |
PS Ratio | 0 |
Forward PS | 5.4 |
PB Ratio | 1.13 |
P/FCF Ratio | -1.84 |
PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Vigil Neuroscience Inc..
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.45, with a Debt / Equity ratio of 0.
Current Ratio | 10.45 |
Quick Ratio | 10.45 |
Debt / Equity | 0 |
Total Debt / Capitalization | 0 |
Cash Flow / Debt | 0 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.71% and return on capital (ROIC) is -68.3%.
Return on Equity (ROE) | -0.71% |
Return on Assets (ROA) | -0.59% |
Return on Capital (ROIC) | -68.3% |
Revenue Per Employee | 0 |
Profits Per Employee | -1.29M |
Employee Count | 64 |
Asset Turnover | 0 |
Inventory Turnover | 0 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -44.41% in the last 52 weeks. The beta is 1.93, so Vigil Neuroscience 's price volatility has been higher than the market average.
Beta | 1.93 |
52-Week Price Change | -44.41% |
50-Day Moving Average | 2.71 |
200-Day Moving Average | 3.33 |
Relative Strength Index (RSI) | 39.9 |
Average Volume (20 Days) | 212.18K |
Income Statement
Revenue | n/a |
Gross Profit | -399.00K |
Operating Income | -88.87M |
Net Income | -82.64M |
EBITDA | -88.47M |
EBIT | n/a |
Earnings Per Share (EPS) | -2.13 |
Balance Sheet
The company has 51.99M in cash and 13.85M in debt, giving a net cash position of 38.14M.
Cash & Cash Equivalents | 51.99M |
Total Debt | 13.85M |
Net Cash | 38.14M |
Retained Earnings | -222.77M |
Total Assets | 131.27M |
Working Capital | 83.14M |
Cash Flow
In the last 12 months, operating cash flow was -70.36M and capital expenditures -674.00K, giving a free cash flow of -71.04M.
Operating Cash Flow | -70.36M |
Capital Expenditures | -674.00K |
Free Cash Flow | -71.04M |
FCF Per Share | -1.84 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
VIGL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -115.76% |
FCF Yield | -94.44% |
Analyst Forecast
The average price target for VIGL is $19.5, which is 959.8% higher than the current price. The consensus rating is "Buy".
Price Target | $19.5 |
Price Target Difference | 959.8% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Scores
Altman Z-Score | -3.53 |
Piotroski F-Score | 2 |